MENU
HSIC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

HSIC stock forecast, quote, news & analysis

Henry Schein Inc is a solutions company for healthcare professionals... Show more

Interact to see
Advertisement
A.I.Advisor
published price charts
HSIC
Daily Signal:
Gain/Loss:
A.I.Advisor
a Summary for HSIC with price predictions
Oct 09, 2026

HSIC in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 17, 2026

HSIC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 22 of 34 cases where HSIC's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 65%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 30 of 55 cases where HSIC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 55%.

Following a +1.55% 3-day Advance, the price is estimated to grow further. Considering data from situations where HSIC advanced for three days, in 162 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 55%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HSIC as a result. In 63 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.

HSIC moved below its 50-day moving average on September 15, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HSIC crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 56%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HSIC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.

The Aroon Indicator for HSIC entered a downward trend on October 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. HSIC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.036) is normal, around the industry mean (2.488). P/E Ratio (25.070) is within average values for comparable stocks, (39.020). Projected Growth (PEG Ratio) (1.715) is also within normal values, averaging (2.016). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (0.750) is also within normal values, averaging (4.260).

The Tickeron SMR rating for this company is 63 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 85 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HSIC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 21.94B. The market cap for tickers in the group ranges from 44.8K to 99.84B. MCK holds the highest valuation in this group at 99.84B. The lowest valued company is COCM at 44.8K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 1%. For the same Industry, the average monthly price growth was 4%, and the average quarterly price growth was -22%. AHG experienced the highest price growth at 11%, while ACH experienced the biggest fall at -15%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was -34%. For the same stocks of the Industry, the average monthly volume growth was -2% and the average quarterly volume growth was -0%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 59
Price Growth Rating: 54
SMR Rating: 87
Profit Risk Rating: 72
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
HSIC
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a distributer of healthcare products and services

Industry MedicalDistributors

Industry
Medical Distributors
Address
135 Duryea Road
Phone
+1 631 843-5500
Employees
25000
Web
https://www.henryschein.com
HSIC in upward trend: price expected to rise as it breaks its lower Bollinger Band on September 17, 2026